All countries
Global lab filtration market to hit $6.8b by 2030 on biopharma demand
Global lab filtration market to hit $6.8b by 2030 on biopharma demand
Demand for sterile and membrane filtration is expected to rise across global labs.
2 days ago
Pharma AI stays stuck in pilot as drugmakers chase output
Digital twins are being tested to improve existing factory capacity.
4 days ago
DEE market to surge almost 12% annually on gene therapy advances
Patient pool rises to 326,000 by 2036 across 7MM as diagnosis rates increase.
Alcohol-linked liver disease market to see 31% annual growth in next decade
In 2025, the market size was at $145m.
Chronic conditions fuel demand as pneumonia market expands
It is primarily driven by the ageing population.
UTI testing market to reach $78.9b by 2036 on antibiotic resistance, diagnostic demand
India and China are emerging as significant centres due ti high investment.
Capsule endoscopy market to reach $2.15b by 2033 on GI disease surge
Capsule endoscopy does not support treatment.
Apheresis market to hit $4.4b by 2031 on autoimmune, surgical demand
Asia Pacific is estimated to record the highest CAGR.
Biologics adoption to fuels trillion-dollar injectable market expansion
China and India are emerging as key manufacturing and consumption centres.
Rising elderly cancer burden to expand T-cell malignancies market
Advances in molecular profiling help improve the understanding of these diseases.
Global point‑of‑care testing market to hit $64.8b by 2031
This will be driven by increasing demand for quick testing.
Radiation safety market to hit $5.7b by 2031 on nuclear, medical demand
It is projected to expand at 8.4% CAGR.
Chronic diseases to drive MRI systems market 2031 expansion to $9.68b
The ultra-high-field MRI systems segment is expected to have the highest CAGR.
Acute myocardial infarction market hits $1.60b in 2025 across leading markets
Seven major markets record 1.5-million heart attack cases in 2025.
Ostomy dressing market to see $4.73b spike in 2031 as cancer cases surge
Europe will hold the largest share of the market.
CKD blood pressure therapy cuts cardiovascular risk across all stages, study finds
The analysis spans 46 trials, covering 285,124 patients.
Solengepras shows promise in easing Parkinson's overlooked non-motor burden
This signals a growing focus on holistic Parkinson’s disease management.
Read Here
Advertise
Sign Up
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention
How the healthcare ecosystem is responding to change the trajectory of myopia